ANTIVERT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Antivert, and what generic alternatives are available?
Antivert is a drug marketed by Casper Pharma Llc and is included in one NDA.
The generic ingredient in ANTIVERT is meclizine hydrochloride. There are seventeen drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the meclizine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Antivert
A generic version of ANTIVERT was approved as meclizine hydrochloride by INVATECH on May 22nd, 1989.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ANTIVERT?
- What are the global sales for ANTIVERT?
- What is Average Wholesale Price for ANTIVERT?
Summary for ANTIVERT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 12 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Clinical Trials: | 2 |
| Patent Applications: | 4,107 |
| Drug Prices: | Drug price information for ANTIVERT |
| What excipients (inactive ingredients) are in ANTIVERT? | ANTIVERT excipients list |
| DailyMed Link: | ANTIVERT at DailyMed |
Recent Clinical Trials for ANTIVERT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Philip Morris USA, Inc. | Phase 2 |
| Duke University | Phase 2 |
| Lehigh Valley Hospital | N/A |
Pharmacology for ANTIVERT
| Drug Class | Antiemetic |
| Physiological Effect | Emesis Suppression |
US Patents and Regulatory Information for ANTIVERT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Casper Pharma Llc | ANTIVERT | meclizine hydrochloride | TABLET, CHEWABLE;ORAL | 010721-005 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Casper Pharma Llc | ANTIVERT | meclizine hydrochloride | TABLET;ORAL | 010721-001 | Jan 20, 1982 | AA | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Casper Pharma Llc | ANTIVERT | meclizine hydrochloride | TABLET;ORAL | 010721-006 | Approved Prior to Jan 1, 1982 | AA | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Casper Pharma Llc | ANTIVERT | meclizine hydrochloride | TABLET;ORAL | 010721-004 | Approved Prior to Jan 1, 1982 | AA | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
